Volume dodolan perusahaan Notable Labs (NTBL)

Lambang korporat lan logo notablelabs.com (NTBL)

Notable Labs, Ltd. (NTBL) is developing an IT solution for therapy selection while facing challenges related to clinical validation and partnership costs. Revenue is based on precision diagnostics of patient drug responses. The current pre-revenue stage and linear growth of expenses are hindering scalability. The company's commercial sales metric has reached 0.00, as clearly demonstrated by this chart.

NTBL Notable Labs Ltd: Dodolan perusahaan ing interval 21.02.2024 - 02.11.2024

Rincian metrik komprehensif lan analitis Notable Labs Inc. (NTBL)

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:Notable Labs, Ltd.
Barang utama Notable Labs Ltd

The retention of unique AI specialists and biologists at Notable Labs, Ltd. (NTBL) converts directly into the commercial value of developed therapies. This metric aggregates the total cash flow from service delivery, reflecting the efficiency of intellectual capital monetization through the volume of market transactions. An analysis of the company's sales profile allows for an assessment of the balance between operational income stability and the asset's capitalization growth potential.

Pesaing wigati

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ascentage Pharma Corp AAPG|Total volume dodolan perusahaan CG Oncology, Inc.|URGN - Pendapatan perusahaan|Bicara Therapeutics Inc. (BCAX) - Dodolan perusahaan|Personalis Inc (PSNL) - Pendapatan perusahaan|ERAS - Pendapatan reged perusahaan|DCTH (Delcath Systems Inc) - Pendapatan lan volume dodolan|Pendapatan perusahaan YMAB|Pendapatan lan volume dodolan AURA|Pendapatan perusahaan CADL (Candel)|Accuray, Inc. - Dodolan perusahaan|SELLAS Life Sciences Group Inc. - Pendapatan perusahaan|ACTU: Dodolan perusahaan|Total pendapatan perusahaan Citius Oncology Inc|HURA: Pendapatan lan volume dodolan|TARA: Total dodolan perusahaan|FATE (fatetherapeutics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Aadi Bioscience Inc (WHWK)|Pendapatan lan volume dodolan TCRX|CSBR - Total pendapatan perusahaan|Pendapatan lan volume dodolan XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Total pendapatan perusahaan|OSTX: Dodolan perusahaan|Pendapatan dodolan perusahaan RADX (Radiopharm Theranostics)|Artiva (ARTV) - Pendapatan perusahaan|ANL: Total dodolan perusahaan|VERU (Veru Corporation) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tempest Therapeutics, Inc. TPST|Pendapatan lan volume dodolan XLO|Renovaro - Volume dodolan perusahaan|Pendapatan perusahaan Mural Bio MURA|KAPA: Volume dodolan perusahaan|OnKure Therapeutics - Pendapatan lan volume dodolan|Pendapatan reged perusahaan w2.cytomed.sg GDTC|CRIS: Pendapatan lan volume dodolan|Dodolan perusahaan Apollomics Inc.|THAR (Tharimmune Corporation) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Advanced Biomed Inc|Pendapatan lan volume dodolan GNPX|Dodolan perusahaan Calidi Biotherapeutics Inc. CLDI|Pendapatan perusahaan Sunshine Biopharma Inc. SBFM|Pendapatan reged perusahaan Xenetic Biosciences (XBIO)|SLRX - Pendapatan perusahaan|Total pendapatan perusahaan Kitov Pharma|AON (AONC) - Pendapatan perusahaan|Dodolan perusahaan BeiGene|Pendapatan perusahaan checkpointtx.com|Volume dodolan perusahaan ELEV (Elevation Oncology)|Pendapatan lan volume dodolan ICAD|Ikena Oncology - Volume dodolan perusahaan|Pendapatan perusahaan viracta.com VIRX|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan